Contract notice: Pharmaceutical products Tender in Poland - 37448329
Tender notice from Poland, published on 25 Oct 2019.
Executive Summary
The SZPITAL SPECJALISTYCZNY W ZABRZU SP. Z O.O. has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Poland. This Tender notice was published on 25 Oct 2019 and is scheduled to close on 02 Dec 2019, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 37448329, while the tender notice number is 504066-2019 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Body governed by public law Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union, with participation by GPA countries Award criteria: The most economic tender CPV code: 33600000, 33600000, 33680000, 33690000, 24322510, 33141540, 33141550, 33622100, 33630000, 33631000, 33631400, 33650000, 33651600, 33651680, 33652000, 33652300, 33661100, 33661200, 33661500, 33661600, 33670000, 33674000, 33675000, 33691100, 33691200, 33692000, 33692100, 33692200, 33692300, 33692500, 33692510, 33692700, 33693000, 33697100, 33600000, 33680000, 33690000, 24322510, 33141540, 33141550, 33622100, 33630000, 33631000, 33631400, 33650000, 33651600, 33651680, 33652000, 33652300, 33661100, 33661200, 33661500, 33661600, 33670000, 33674000, 33675000, 33691100, 33691200, 33692000, 33692100, 33692200, 33692300, 33692500, 33692510, 33692700, 33693000, 33697100 CPV Description: Pharmaceutical products. Pharmaceutical articles. Various medicinal products. Ethyl alcohol. Albumin. Heparin. Cardiac therapy medicinal products. Medicinal products for dermatology and the musculo-skeletal system. Medicinal products for dermatology. Antibiotics and chemotherapeutics for dermatological use. General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. Vaccines. Hepatitis B vaccines. Antineoplastic and immunomodulating agents. Immunosuppressive agents. Anaesthetics. Analgesics. Psycholeptics. Psychoanaleptics. Medicinal products for the respiratory system. Cough and cold preparations. Antihistamines for systemic use. Antiprotozoals. Anthelmintics. Medical solutions. Infusion solutions. Parenteral nutrition products. Enteral feeds. Injectablesolutions. Intravenous fluids. Glucose solutions. Other therapeutic products. Enema preparations. Supply of medicinal and prescription products for the Specialist Hospital in Zabrze Sp. z o.o. DZP / 12PN / 2019 Reference Number: DZP / 12PN / 2019 Supply of medicinal and prescription products for the Specialist Hospital in Zabrze Sp. z o.o. DZP / 12PN / 2019 Main Site: Specialist Hospital in Zabrzu Sp. z o.o. - A detailed description of the subject of the order is attached as Annex 5 to the ToR The assortment and price form, - Detailed requirements for the order are described in the ToR III.2, - Subject conditions required of Contractors described in SIWZ chapter III.3 SIWZ Chapter XIII.3.1 Permissions: 1. The contractor must be authorized to conduct business in the field of Provpharmaceutical wholesaler in accordance with the Act of 06.09.2001. Pharmaceutical Law (Journal of Laws 2019.499, i.e. from 2019.03.15 as amended) 2. The Contractor must be authorized to manufacture medicinal products (if the Contractor is the manufacturer) or to run a pharmaceutical warehouse in the wholesale trade in narcotic drugs and psychotropic substances in accordance with art.38 and art. 74 section 5 of the Act of September 6, 2001 Pharmaceutical Law (i.e. Journal of Laws 2019.499, i.e. from art. 40 of the Act of July 29, 2005 on counteracting drug addiction (i.e. Journal of Laws 2019.852 i.e. from 2019.05.08) - applies to the Contractor submitting an offer for narcotic drugs or psychotropic substances described in Package No. 1 Note (applies to the condition of point 3.1 .) WSingle European Order Form (EAT) form in Section A of Part IV, the Contractor shall indicate the possessed powers referred to in point 3.1 required by the Employer pursuant to art. 22 paragraph 1b of the Act. SIWZ.XIII.4.4. The contractor whose bid is the highest rated in order to demonstrate compliance with the conditions for participation in the procedure (point 3.1. Of this section of the ToR) will be calledto submit the following statements and documents (current as at the date of submission of the statements or documents): - to demonstrate compliance with the condition of point 3.1.: 4.4.1. original or copy, certified by the Contractor for compliance with the original permission of the Chief Pharmaceutical Inspector to conduct business in the field of running a pharmaceutical warehouse in accordance with the Act ofSeptember 6, 2001 Pharmaceutical Law (i.e. Journal of Laws 2019.499, i.e. from March 03, 15, as amended). 4.4.2. original or copy, certified by the Contractor for compliance with the original permission of the Chief Pharmaceutical Inspector for the manufacture of medicinal products (if the Contractor is the manufacturer) or for operating a pharmaceutical warehouse in the field of wholesale trade in narcotic drugs and substancespsychotropic in accordance with art. 38 and art. 74 section 5 of the Act of September 6, 2001 Pharmaceutical Law (i.e. Journal of Laws 2019.499, i.e. from art. 40 of the Act of July 29, 2005 on counteracting drug addiction (i.e. Journal of Laws 2019.852 i.e. from 05.05.08) - applies to the Contractor submitting an offer for narcotic drugs or psychotropic substances described in Package No. 1 Uwaga (applies to points 4.4.1-4.4.2) In the case of Contractors whose registered office is in a Member State of the European Union other than Poland, an original or a copy, certified by the Contractor for compliance with the original of the authorization for operating a pharmaceutical warehouse, issued by the competent authority in the Member State of the European Union in which the Contractor is establishedor place of residence, unless such permission is not required in a given country The Purchaser does not set specific conditions in this respect. 1. The subject conditions required from the Contractors are described in SIWZ chapter III point 3 2. Information on the possibility of submitting a joint bid has been described in SIWZ chapter X 3 . To confirm that the offered deliveries meet the requirements ofdrafted by the Employer (Annex 5 to the ToR regarding the description of the subject of the order) the offer should be attached with the current as at the day of submission of offers (SIWZ.XIII.4.2.): - Annex 5 to the ToR regarding the description of the subject of the order assortment and price form Documents submitted at each request: - CHPL Card (Summary of Product Characteristics) for the medicines offered - CHPL (Summary of Product Characteristics)medicinal product) for the equivalent medicine offered 4. The offer must be secured by a bid bond in accordance with the provisions of the ToR, chapter XIX The deposit is set up in the amount of PLN 25, 298, which includes the following parts: Package No. 1 12 030 PLN Package No. 2 1 330 PLN Package No. 3 24 PLN Package No. 4 2 704 PLN Package No. 5 9 210 PLN When submitting an offer for more than one task, a security deposit should be lodgedin the total amount corresponding to the sum for individual packages for which the offer is submitted. When submitting the bid security, please indicate which packages are affected. 5. The Employer informs that the numbering given in the Advertisement is consistent with the numbering adopted in the ToR. 6. The Awarding Entity will exclude the Contractor from the proceedings in the cases referred to in Article 24 (1) points 12-23 of the Act (grounds for exclusionobligatory) in accordance with the ToR chap. XIII. point 2. In order to demonstrate the lack of grounds for exclusion from the procedure, the offer should be accompanied by a statement valid as at the date of submission of tenders, in the form of the Single European Order Document Form (EAT) - Annex 2 to the ToR. The information contained in JEDZ constitutes preliminary confirmation that the Contractor is not subject to exclusion from the procedure. EAT nsubmitted together with the offer, in a separate file in electronic form with a qualified electronic signature. In order to demonstrate the lack of grounds for exclusion from the contract award procedure, the contractor whose tender is the highest rated will be asked to submit: - Information from the National Criminal Record in the scope specified in art. 24ust. 1 point 13, 14 and 21 of the Act, not earlier than 6 months before the deadline for submission of bids, - the Contractor's declaration that he has not issued a final court judgment or final administrative decision regarding late payment of taxes, fees or social security contributions or in the case of such a judgment or decision documents confirming payment of thesereceivables with any interest or fines or conclusion of a binding agreement on the repayment of these receivables (according to EED information Part III.B), - the Contractor's statement that there was no decision against him as a precautionary measure forbidding public procurement (as per JEDZ information part III.D). 7. The awarding entity does not envisage the award of orderswa in art. 67 section 1 item 7 of the Public Procurement Law 8. INFORMATION CLAUSE ARISING FROM ARTICLE 13 and ARTICLE 14 GDPR described in SIWZ chapter XIX. 9. When choosing the most advantageous offer, the Employer will be guided by the following criteria: price 90%, order completion time 10%. Internet address (URL): www.klinika-zabrze.med.pl
The bid deadline for Contract notice: Pharmaceutical products was 02 Dec 2019. Bidding is closed.
This tender has been issued by SZPITAL SPECJALISTYCZNY W ZABRZU SP. Z O.O. in Poland.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33680000 - Pharmaceutical articles, 33690000 - Various medicinal products, 24322510 - Ethyl alcohol, 33141540 - Albumin, 33141550 - Heparin, 33622100 - Cardiac therapy medicinal products, 33630000 - Medicinal products for dermatology and the musculo-skeletal system, 33631000 - Medicinal products for dermatology, 33631400 - Antibiotics and chemotherapeutics for dermatological use, 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, 33651600 - Vaccines, 33651680 - Hepatitis B vaccines, 33652000 - Antineoplastic and immunomodulating agents, 33652300 - Immunosuppressive agents, 33661100 - Anaesthetics, 33661200 - Analgesics, 33661500 - Psycholeptics, 33661600 - Psychoanaleptics, 33670000 - Medicinal products for the respiratory system, 33674000 - Cough and cold preparations, 33675000 - Antihistamines for systemic use, 33691100 - Antiprotozoals, 33691200 - Anthelmintics, 33692000 - Medical solutions, 33692100 - Infusion solutions, 33692200 - Parenteral nutrition products, 33692300 - Enteral feeds, 33692500 - Injectable solutions, 33692510 - Intravenous fluids, 33692700 - Glucose solutions, 33693000 - Other therapeutic products, 33697100 - Enema preparations.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 37448329. The purchaser document reference is 504066-2019.